Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News What clinicians and regulators will watch next after Itvisma’s positive CHMP opinion Novartis Pharma AG’s Itvisma gains CHMP backing. Discover what clinicians, regulators, and investors will watch next in SMA gene therapy. bySoujanya RaviApril 26, 2026